Related Experiment Videos
Risk factors and pathogenesis of posttransplant lymphoproliferative disorders
M Ho1
1Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261, USA.
Transplantation Proceedings
|October 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope.
Proceedings of the National Academy of Sciences of the United States of America·2024
Comparison of United Kingdom and United States screening criteria for detecting retinopathy of prematurity in Hong Kong.
Hong Kong medical journal = Xianggang yi xue za zhi·2023
Prevalence of lower limb venous disease in surgeons: a case study and results of a survey by the BAOMS Reconstruction Surgical Subspecialty Interest Group.
The British journal of oral & maxillofacial surgery·2021
Investigating Risk Factors for Falls among Community-Dwelling Older Adults According to WHO's Risk Factor Model for Falls.
The journal of nutrition, health & aging·2021
A Modified Approach to Dual Kidney Transplantation.
Transplantation proceedings·2026
Demographic, Clinical, and Allocation Shifts in the US Lung Transplant Waitlist: A National SRTR Study (2012-2023).
Transplantation proceedings·2026
Global Status and Research Trends of Heart Transplantation: A Bibliometrics Analysis.
Transplantation proceedings·2026
Fatty Acid Metabolic Reprogramming in Rheumatoid Arthritis: Integrating Inflammation, Resolution Failure, and Joint Destruction.
Journal of inflammation research·2026
Sporadic lymphangioleiomyomatosis with lymphocyte-predominant pleural effusion misdiagnosed as tuberculosis: a case report.
Respiratory medicine case reports·2026
Epitope-Specific Thyroid Peroxidase Antibodies Reveal Functional Heterogeneity Within a Patient-Derived Monoclonal Repertoire.
Clinical and experimental immunology·2026